title: Congestive heart failure due to systolic dysfunction: the Cinderella of cardiovascular management in dialysis patients.
abstract: Cardiac disease is common in dialysis patients. Survival is poorest in the subgroup with systolic dysfunction (pump failure). Audits show that cardiovascular management of dialysis patients in general, and treatment of congestive heart failure (CHF) specifically, is generally not in agreement with recommendations based on evidence obtained from controlled trials, admittedly in nonrenal patients. The pathophysiology underlying CHF and the rationale underlying interventions are discussed in an effort to heighten awareness of this important clinical problem in the dialysis community.
authors.forename: Eberhard
authors.initials: E
authors.lastname: Ritz
authors.forename: Ralf
authors.initials: R
authors.lastname: Dikow
authors.forename: Marcin
authors.initials: M
authors.lastname: Adamzcak
authors.forename: Martin
authors.initials: M
authors.lastname: Zeier
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000740:Anemia / Q000628:therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D006435:Renal Dialysis; D013148:Spironolactone / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D013148:Spironolactone